Work

Histological differentiation of skin toxicity between cetuximab, erlotinib and panitumumab (single ErbB1) and lapatinib (dual ErbB1/2) epidermal growth factor receptor inhibitors

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.e20617

Authors: M. Newman, P. Gerami, J. Guitart, T. Lertsburapa, D. West, S. Rosen, M. Cianfrocca, M. Lacouture

Institution: Northwestern University

Language: English

Topic: Chemotherapy-related skin toxicity

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2244035546

Cites:

Cited by: 4

Related to: 10